Can't discount the influence of lobbyists that don't want Brilacidin on the market for any indication. In these times of special actions, their influence is extra strong.
I think individual institutions will run clinical trials with IPIX providing the drug. I am not expecting monetary assistance from the government with regard to Brilacidin. This industry is dirty and none of the power players want Brilacidin on the docket.
News 
Market Data 
Discover 
